BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

about

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

Item

http://www.wikidata.org/entity/Q49208897

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@en

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@nl

type

Item

label

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@en

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@nl

prefLabel

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@en

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@nl

P1476

BAFF and APRIL expression as an autoimmune signature of membranous nephropathy.

@en

P2093

Chun Soo Lim

http://www.w3.org/2001/XMLSchema#string

Dong Ki Kim

http://www.w3.org/2001/XMLSchema#string

Hajeong Lee

http://www.w3.org/2001/XMLSchema#string

Joo Young Kim

http://www.w3.org/2001/XMLSchema#string

Jung Pyo Lee

http://www.w3.org/2001/XMLSchema#string

Kwon Wook Joo

http://www.w3.org/2001/XMLSchema#string

Minkyoung Park

http://www.w3.org/2001/XMLSchema#string

Sang-Ho Lee

http://www.w3.org/2001/XMLSchema#string

Seung Hee Yang

http://www.w3.org/2001/XMLSchema#string

Seung Seok Han

http://www.w3.org/2001/XMLSchema#string

P2860

APRIL modulates B and T cell immunity

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

A new equation to estimate glomerular filtration rate

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

TALL-1 is a novel member of the TNF family that is down-regulated by mitogens

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial).

Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.

P304

3292-3302

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23232

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hyung Ah Jo

P577

2017-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29423047

http://www.w3.org/2001/XMLSchema#string

P932

5790464

http://www.w3.org/2001/XMLSchema#string